Wen's Group visited Sheng'ao Pharmaceutical for inspection and exchange

On July 18, Mr. Liao and his colleagues from Wens Group visited Sheng'ao Pharmaceutical for inspection and guidance. Du Yufeng, General Manager of Sheng'ao Pharmaceutical, and other company executives warmly received the guests.

On-site Visit: In-depth Understanding of Sheng'ao Pharmaceutical's Core Advantages

In the product showroom and honor showroom, Sales Director Zhou Qi gave the guests a detailed introduction to the company's development history, scientific research strength, core technologies, and the advantages of various products. After fully understanding our company's product positioning, R&D model, and development plan, Wens Group fully affirmed and highly recognized Sheng'ao Pharmaceutical's strength in core technologies, operation models, and application research and development.

Symposium: Focusing on Collaborative Innovation and Cost Optimization

At the subsequent symposium, General Manager Du Yufeng extended a warm welcome to the Wens Group delegation. He pointed out that as a pioneer in injectable veterinary products, Sheng'ao Pharmaceutical has always adhered to the concept of "technology-driven, quality-based survival, and innovation-driven development," and has been deeply involved in the production and research and development in this field. With the deepening of cooperation with Wens Group, the company has invested resources to build a second final sterilization large-volume intravenous injection (blow-fill-seal) production line and complete the expansion project of the powder injection (blow-fill-seal) production line to better meet the rapidly growing needs of Wens Group. General Manager Du emphasized that he hopes the two sides will further strengthen communication and interaction, strengthen collaboration, and strive to achieve a deeper and higher level of mutual benefit and win-win results.

Mr. Liao from Wens Group expressed his sincere gratitude for Sheng'ao Pharmaceutical's long-term support and briefly introduced Wens Group's full industrial chain ecosystem and supplier management system. He stated that Wens Group attaches great importance to its cooperation with Sheng'ao Pharmaceutical and hopes that both sides will jointly explore new business scenarios and work together to promote the collaborative development of the upstream and downstream of the animal husbandry and veterinary industry.

Sales Director Zhou Qi gave a systematic introduction to the company's core qualifications, development history, and strategic planning, and detailed the company's professional accumulation and core advantages in the field of injectable veterinary products. From the continuous innovation of the technical team to the active participation in the formulation of industry standards, from the professional focus on product categories to the full coverage of the service system, Director Zhou, through detailed and vivid examples, fully demonstrated the company's solid foundation and enterprising spirit in the veterinary drug industry.

In her speech, Deputy General Manager Zhao Mengting focused on the efficiency and cost optimization of the cooperation projects between the two parties. Combining detailed data and specific cases, she deeply analyzed the common problems in the current cooperation, especially the detailed analysis of the cost structure. Deputy General Manager Zhao put forward targeted optimization suggestions and conducted pragmatic discussions with the visiting guests from Wens Group on how to explore the potential for cost reduction and improve overall efficiency in existing cooperation projects, jointly exploring feasible solutions.

Following this, the two sides conducted in-depth exchanges on the two core issues of business collaboration and innovative cooperation in a friendly and harmonious atmosphere. Participants expressed their opinions and fully discussed industry development trends, market opportunities, and potential future cooperation directions.

This inspection and exchange activity not only significantly enhanced Wens Group's understanding of Sheng'ao Pharmaceutical's comprehensive strength but also laid a solid foundation for future in-depth cooperation between the two parties. In the future, Sheng'ao Pharmaceutical will continue to adhere to the concept of open win-win cooperation, deepen strategic cooperation with Wens Group, achieve resource sharing and complementary advantages, work together to seek common development, and open up a new situation for cooperation.